Literature DB >> 8575577

Allergic sensitization is associated with increased bronchial responsiveness: a prospective study of allergy to laboratory animals.

A Renström1, P Malmberg, K Larsson, P H Larsson, B M Sundblad.   

Abstract

The purpose of this prospective study was to investigate the extent of change in bronchial responsiveness and the prognostic value of methacholine provocation in early sensitization to laboratory animals. Thirty eight laboratory technicians were studied during training (before first exposure) and after having been exposed to laboratory animals for a median 18 (range 5-33) months. On both occasions they were subjected to spirometry, bronchial methacholine challenge, skin-prick tests and blood sampling, and responded to questionnaires. Nine (24%) developed laboratory animal allergy (LAA), defined as animal work-related symptoms (n = 8), or specific immunoglobulin E (IgE) (n = 7) or both. In the LAA group, bronchial responsiveness was normal before employment, but had increased significantly at follow-up compared to technicians who had not developed LAA. Six of the nine LAA subjects had a more than threefold increase in bronchial responsiveness, and three of these reported chest symptoms. Spirometric values were not different between the groups prior to exposure or at follow-up, and had no prognostic value. However, a pre-employment level of total IgE > 100 kU.L-1 predicted the development of LAA (relative risk 2.8). Thus, early LAA was associated with increased bronchial responsiveness in most subjects. In contrast to total IgE, the level of pre-employment bronchial responsiveness or lung function did not influence the magnitude of change in responsiveness, nor predict sensitization.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8575577

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

1.  Lung function decline in laboratory animal workers: the role of sensitisation and exposure.

Authors:  L Portengen; A Hollander; G Doekes; G de Meer; D Heederik
Journal:  Occup Environ Med       Date:  2003-11       Impact factor: 4.402

2.  One-year longitudinal study of young apprentices exposed to airway occupational sensitizers.

Authors:  Donatella Talini; Andrea Monteverdi; Lamberto Lastrucci; Cesare Buonocore; Maria Carrara; Francesco Di Pede; Pierluigi Paggiaro
Journal:  Int Arch Occup Environ Health       Date:  2005-10-19       Impact factor: 3.015

3.  Is there a need for special preventive medical check-ups in employees exposed to experimental animal dust?

Authors:  Klaus Schmid; Barbara Jüngert; Meta Hager; Hans Drexler
Journal:  Int Arch Occup Environ Health       Date:  2008-06-20       Impact factor: 3.015

4.  Exposure-response relations among laboratory animal workers exposed to rats.

Authors:  M J Nieuwenhuijsen; V Putcha; S Gordon; D Heederik; K M Venables; P Cullinan; A J Newman-Taylor
Journal:  Occup Environ Med       Date:  2003-02       Impact factor: 4.402

5.  Predictors for Increased and Reduced Rat and Mouse Allergen Exposure in Laboratory Animal Facilities.

Authors:  Anne Straumfors; Wijnand Eduard; Knut Andresen; Ann Kristin Sjaastad
Journal:  Ann Work Expo Health       Date:  2018-10-15       Impact factor: 2.179

6.  Laboratory animals and respiratory allergies: the prevalence of allergies among laboratory animal workers and the need for prophylaxis.

Authors:  Erica Ferraz; Luisa Karla de Paula Arruda; Ericson Bagatin; Edson Z Martinez; Andrea A Cetlin; Christian S Simoneti; Amanda S Freitas; José A B Martinez; Marcos C Borges; Elcio O Vianna
Journal:  Clinics (Sao Paulo)       Date:  2013-06       Impact factor: 2.365

7.  Prevalence of occupational allergy in medical researchers exposed to laboratory animals.

Authors:  Basilua Andre Muzembo; Masamitsu Eitoku; Yuta Inaoka; Makiko Oogiku; Mitomo Kawakubo; Ryuta Tai; Momoko Takechi; Ken-ichi Hirabayashi; Naofumi Yoshida; Nlandu Roger Ngatu; Ryoji Hirota; Bernardus Sandjaya; Narufumi Suganuma
Journal:  Ind Health       Date:  2014-02-28       Impact factor: 2.179

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.